Explore Curo’s research catalog and lot-level COAs.
Reported closure and current questions · Updated October 13, 2026
Amino Asylum's original storefront reportedly went offline in June 2025, according to the September 22, 2026 account of the reported events. That account does not link a government or court document establishing a warehouse action against Amino Asylum. The closure reports, the identity of later storefronts and the checks for replacement suppliers are separate questions.
For research materials and lot documents, explore Curo’s full research catalog or view kits for Retatrutide, GHK-Cu and KLOW.
For further reading, visit Curo Insights.
The dated Amino Asylum account reports an offline storefront in June 2025; it does not establish the reported warehouse action through a linked primary record.
A familiar brand name or an old review does not verify who runs a present-day storefront.
Replacement suppliers should provide lot-matched COAs and an identifiable company, with records researchers can save.
Check a replacement supplier's exact lot reports and issuing laboratory before comparing prices.
The September 22 account describes reports of an Amino Asylum warehouse action, followed by an offline storefront and unresolved orders in June 2025. It does not name the original reporting outlet or link a primary document for the action. Those limits prevent treating the account as a verified FDA raid or a court finding.
Before June 2025, the company ran an online storefront for research products. Sites with similar branding appeared later, which raises a separate identity question covered below. A longer write-up sets out the documented records and open questions behind each report.
The linked account does not supply an agency announcement, indictment or complaint naming Amino Asylum. That is a limit of the cited evidence, not proof that no such document exists anywhere. A dated government or court record would be needed before presenting the reported action as an established enforcement event.
The Department of Justice case page on United States v. Matthew Kawa is a documented record, but it concerns a different company, Paradigm Peptides. It lists guilty pleas on December 10, 2025 and sentencing on July 30, 2026. It does not name Amino Asylum, so the two matters should stay separate.
Public materials leave several basic questions open:
Which agencies took part in the action.
Under what legal authority, if any, the action took place.
Whether records, products or funds were collected.
Who ran the operation when the store went offline.
What happened to each pending order or payment.
Later articles that repeat one another cannot fill these gaps, but a primary document could.
The cited Amino Asylum account does not establish who operates a present-day storefront or its continuity with the former operator. Check each domain's legal entity, contact details and lot records directly. A familiar logo, catalogue layout or claim of new management cannot establish company identity on its own.
The same caution applies to Amino Asylum reviews. Reviews written before June 2025 describe the original storefront as it operated then. They say nothing about a current site, its inventory or its lot records, and they do not show who runs a domain today.
Researchers choosing an Amino Asylum alternative need to qualify the supplier and its current lots. The supplier checklist covers company records, and the COA reading guide explains which analytical fields connect a report to the material.
Confirm that the product page, label and COA share one lot number. A report for the same compound but a different lot does not show what was measured in the one on offer.
Confirm that an independent laboratory issued the COA. The report ID, sample description, methods and date can be checked with that laboratory directly.
Save the listing, COA, invoice, fulfillment details and supplier messages with the project file, outside the storefront.
Review operations separately from analysis. A COA describes a submitted sample. It says nothing about inventory control, shipping origin, support or refund terms.
The linked independent testing and lot records article illustrates how supplier reports can be checked. The dated 2026 guide to research peptide companies offers further examples. Apply the same company, lot and laboratory checks to every source.
The linked account reports an Amino Asylum warehouse action in June 2025 but supplies no government or court document establishing it. That source does not support stating that FDA conducted a raid as a confirmed fact. It also cannot prove the absence of all possible enforcement records.
The September 22, 2026 account reports that Amino Asylum's original storefront went offline in June 2025. It does not verify the operator of a current site using that name. Verify the specific domain, company and current lot documents rather than relying on reviews of the former storefront.
No. The Department of Justice page on United States v. Matthew Kawa covers Paradigm Peptides, a different company, and does not name Amino Asylum. It records guilty pleas on December 10, 2025 and sentencing on July 30, 2026. Some summaries blend the two stories, but the page establishes no connection between the businesses.
Check that the product page, label and COA share one lot number, that a named independent laboratory issued the report, and that the report lists its methods and date. Then review shipping origin, payment terms and refund language on their own. A COA describes one sample, not how a supplier operates.
Browse the current research catalogue and check the lot documents in the COA library. Catalogue materials are supplied for research use only, not human or veterinary use.